Page last updated: 2024-08-17

aspartic acid and Gastrointestinal Stromal Neoplasm

aspartic acid has been researched along with Gastrointestinal Stromal Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berner, JM; Bruland, ØS; Holm, R; Joensuu, H; Kristian, A; Malinen, E; Revheim, ME; Seierstad, T1
Bei, T; Boikos, S; Carney, JA; Ferrando, B; Matyakhina, L; Muchow, M; Pasini, B; Stratakis, CA1

Other Studies

2 other study(ies) available for aspartic acid and Gastrointestinal Stromal Neoplasm

ArticleYear
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.
    Acta oncologica (Stockholm, Sweden), 2013, Volume: 52, Issue:4

    Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Aspartic Acid; Benzamides; Drug Administration Schedule; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histidine; Humans; Imatinib Mesylate; Mice; Mice, Nude; Mutation, Missense; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Xenograft Model Antitumor Assays

2013
Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:9

    Topics: Aspartic Acid; Base Sequence; DNA Mutational Analysis; Female; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Humans; Middle Aged; Neoplasms, Multiple Primary; Receptor, Platelet-Derived Growth Factor alpha; Valine

2007